Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis
Abstract
On the basis of the best available data as derived from the literature and experts, the azithromycin strategy was more cost-effective than the doxycycline strategy for women with uncomplicated cervical chlamydial infections. Despite the dominance of the azithromycin strategy over the doxycycline str …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
female
Drug Administration Schedule
Comparative Study
sensitivity and specificity
multivariate analysis
decision trees
analysis of variance
cost-benefit analysis
health care costs
chlamydia infections / drug therapy*
chlamydia trachomatis*
doxycycline / administration & dosage
azithromycin / administration & dosage
genital diseases
female / drug therapy*
chlamydia infections / economics
pmid:8554247
doi:10.7326/0003-4819-124-4-199602150-00002
d magid
j m douglas
j s schwartz
azithromycin / economics*
doxycycline / economics*
female / economics
Access
Citation
ID:
118672
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
118672
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet